Massade, L.
(Вiopolymers and Cell, 2011)
RET/PTC1 fusion oncogene is the most common genetic alteration identified to date in thyroid papillary
carcinomas (PTC) and represents a good target forsmall interfering RNA (siRNA). Our aim was: i) to target the
RET/PTC1 ...